Chevy Chase Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,239
Closed -$215K 697
2017
Q3
$215K Buy
12,239
+5,497
+82% +$96.6K ﹤0.01% 642
2017
Q2
$224K Buy
6,742
+469
+7% +$15.6K ﹤0.01% 631
2017
Q1
$201K Buy
6,273
+207
+3% +$6.63K ﹤0.01% 636
2016
Q4
$220K Sell
6,066
-2,933
-33% -$106K ﹤0.01% 635
2016
Q3
$414K Sell
8,999
-43,073
-83% -$1.98M ﹤0.01% 584
2016
Q2
$2.62M Sell
52,072
-9,299
-15% -$467K 0.01% 526
2016
Q1
$3.28M Sell
61,371
-3,929
-6% -$210K 0.02% 511
2015
Q4
$4.29M Sell
65,300
-5,351
-8% -$351K 0.03% 493
2015
Q3
$3.99M Sell
70,651
-15,162
-18% -$856K 0.02% 492
2015
Q2
$5.07M Sell
85,813
-10,294
-11% -$608K 0.03% 479
2015
Q1
$5.99M Sell
96,107
-30,055
-24% -$1.87M 0.04% 467
2014
Q4
$7.26M Sell
126,162
-10,860
-8% -$625K 0.05% 414
2014
Q3
$7.37M Sell
137,022
-598
-0.4% -$32.1K 0.05% 402
2014
Q2
$7.21M Sell
137,620
-7,672
-5% -$402K 0.05% 394
2014
Q1
$7.68M Sell
145,292
-3,667
-2% -$194K 0.06% 368
2013
Q4
$5.97M Buy
148,959
+25,781
+21% +$1.03M 0.04% 421
2013
Q3
$4.65M Buy
123,178
+53,127
+76% +$2.01M 0.04% 452
2013
Q2
$2.75M Buy
+70,051
New +$2.75M 0.02% 503